Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Feb 15, 2020; 12(2): 205-218
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.205
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.205
Table 2 Characteristics of patient sample (n = 31), n (%)
| Patient characteristic | Number of participants |
| Mean age (range, yr) | 54 (34-82) |
| Gender | |
| Male | 15 (48.4) |
| Female | 16 (51.6) |
| Education | |
| High school grad/GED | 5 (16.1) |
| Some college/Technical degree/AA | 5 (16.1) |
| College degree (BA/BS) | 9 (29.0) |
| Advanced degree (MA, PhD, MD, JD) | 12 (38.7) |
| Race | |
| Caucasian | 26 (83.9) |
| African-American | 3 (9.7) |
| Asian | 1 (3.2) |
| Mixed race | 1 (3.2) |
| ECOG status (self-reported) | |
| 0 | 5 (16.1) |
| 1 | 13 (41.9) |
| 2 | 7 (22.6) |
| 3 | 5 (16.1) |
| 4 | 1 (3.2) |
| Currently on therapy | |
| Yes | 11 (35.5) |
| No | 20 (64.5) |
| Mean (raw score) FACT/GOG-Ntx-13 subscale score (range) | 18.8 (7-38) |
- Citation: Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218
- URL: https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i2.205